• WaveGuide Corporation, a Delaware corporation based in Cambridge, Massachusetts, is in the business of researching and developing its hand-held micro-nuclear magnetic resonance (µNMR) platform technology. The WaveGuide µNMR combines proprietary molecular spectroscopy and diagnostic techniques to provide a system to allow diagnosis and analysis, including in remote settings, thereby reducing cost and improving responsiveness to critical patient/customer needs.
  • The WaveGuide µNMR is expected to enable the low cost, rapid, point-of-care diagnosis of diseases for healthcare; afford a low cost laboratory/university scientific research tool for chemical analysis; provide a logging while drilling (LWD) tool for earlier detection of oil and gas fields; offer a solution to deter theft from oil and gas pipelines; provide asset protection of liquors, food, and pharmaceuticals; and allow for routine testing enabling early detection of failure in machine component systems of military vehicles.
  • As we are in stealth mode we significantly limit what we disclose at this point of time.